RÉSUMÉ
BACKGROUND: In patients resuscitated from cardiac arrest and displaying no ST-segment elevation on initial electrocardiogram (ECG), recent randomized trials indicated no benefits from early coronary angiography. How the results of such randomized studies apply to a real-world clinical context remains to be established. METHODS: We retrospectively analyzed a clinical database including all patients 18 yo or older admitted to our tertiary University Hospital from January 2017 to August 2020 after successful resuscitation of out-of-Hospital (OHCA) or In-Hospital (IHCA) cardiac arrest of presumed cardiac origin, and undergoing immediate coronary angiography, regardless of the initial rhythm and post-resuscitation ECG. The primary outcome of the study was survival at day 90 after cardiac arrest. Demographic data, characteristics of cardiac arrest, duration of resuscitation, laboratory values at admission, angiographic data and revascularization status were collected. Comparisons were performed according to the initial ECG (ST-segment elevation or not), and between survivors and non-survivors. Variables associated with the primary outcome were evaluated by univariate and multivariate regression analyses. RESULTS: We analyzed 147 patients (130 OHCA and 17 IHCA), including 67 with STEMI and 80 without STEMI (No STEMI). Immediate revascularization was performed in 65/67 (97%) STEMI and 15/80 (19%) no STEMI. Day 90 survival was significantly higher in STEMI (48/67, 72%) than no STEMI (44/80, 55%). In the latter patients, survival was not influenced by the revascularization status. In univariate and multivariate analyses, lower age, a shockable rhythm, shorter durations of no flow and low flow, and a lower initial blood lactate were associated with survival in both STEMI and no STEMI. In contrast, metabolic abnormalities, including lower initial plasma sodium and higher potassium were significantly associated with mortality only in the subgroup of no STEMI patients. CONCLUSIONS: Our results, obtained in a real-world clinical setting, indicate that an immediate coronary angiography is not associated with any survival advantage in patients resuscitated from cardiac arrest of presumed cardiac etiology without ST-segment elevation on initial ECG. Furthermore, we found that some early metabolic abnormalities may be associated with mortality in this population, which should deserve further investigation.
Sujet(s)
Réanimation cardiopulmonaire , Coronarographie , Arrêt cardiaque hors hôpital , Intervention coronarienne percutanée , Humains , Études rétrospectives , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Arrêt cardiaque hors hôpital/thérapie , Arrêt cardiaque hors hôpital/mortalité , Arrêt cardiaque hors hôpital/diagnostic , Arrêt cardiaque hors hôpital/imagerie diagnostique , Arrêt cardiaque hors hôpital/physiopathologie , Intervention coronarienne percutanée/mortalité , Intervention coronarienne percutanée/effets indésirables , Facteurs temps , Résultat thérapeutique , Réanimation cardiopulmonaire/effets indésirables , Réanimation cardiopulmonaire/mortalité , Facteurs de risque , Bases de données factuelles , Valeur prédictive des tests , Électrocardiographie , Infarctus du myocarde avec sus-décalage du segment ST/mortalité , Infarctus du myocarde avec sus-décalage du segment ST/thérapie , Infarctus du myocarde avec sus-décalage du segment ST/imagerie diagnostique , Infarctus du myocarde avec sus-décalage du segment ST/diagnostic , Infarctus du myocarde avec sus-décalage du segment ST/physiopathologie , Appréciation des risques , Arrêt cardiaque/thérapie , Arrêt cardiaque/mortalité , Arrêt cardiaque/diagnostic , Arrêt cardiaque/physiopathologie , Arrêt cardiaque/étiologie , Sujet âgé de 80 ans ou plusRÉSUMÉ
BACKGROUND AND PURPOSE: Cerebrovascular events during thrombolysis in cardiac arrest (CA) caused by pulmonary embolism (PE) is a life-threatening condition. However, the balance between cerebrovascular events and thrombolytic therapy in PE-induced CA remains a great challenge. METHODS: In this study, we reported three unique cases regarding main concerns surrounding cerebrovascular events in thrombolytic therapy in PE-induced CA. RESULTS: The patient in the case 1 treated with thrombolysis during CPR and finally discharged neurologically intact. The patient in the case 2 received delayed thrombolysis and died eventually. The patient in the case 3 was contraindicated to thrombolysis due to the complication of subarachioid hemorrahage and died within days. CONCLUSIONS: Our case series highlights three proposed approaches to consider before administering thrombolysis as a treatment option in PE-induced CA patients: (1) prolonging the resuscitation, (2) administering thrombolysis promptly, and (3) ruling out cerebrovascular events.
Sujet(s)
Fibrinolytiques , Arrêt cardiaque , Embolie pulmonaire , Traitement thrombolytique , Humains , Embolie pulmonaire/traitement médicamenteux , Embolie pulmonaire/imagerie diagnostique , Embolie pulmonaire/diagnostic , Embolie pulmonaire/étiologie , Traitement thrombolytique/effets indésirables , Mâle , Arrêt cardiaque/diagnostic , Arrêt cardiaque/étiologie , Arrêt cardiaque/thérapie , Fibrinolytiques/effets indésirables , Fibrinolytiques/administration et posologie , Résultat thérapeutique , Adulte d'âge moyen , Sujet âgé , Issue fatale , Femelle , Réanimation cardiopulmonaire , Facteurs de risque , Délai jusqu'au traitement , Facteurs temps , Prise de décision cliniqueRÉSUMÉ
BACKGROUND: Anomalous aortic origin of a coronary artery from the inappropriate sinus of Valsalva (AAOCA) is a rare congenital heart lesion. It is uncommon for patients with AAOCA to present with severe symptoms at a very young age. CASE PRESENTATION: We describe a very rare but critical presentation in a young infant with AAOCA that requires surgical repair and pacemaker placement. A three-month-old infant was referred because of syncope. Cardiac arrest occurred shortly after admission. The electrocardiogram indicated a complete atrioventricular block and a transvenous temporary pacemaker was implanted. A further coronary computed tomographic angiography (CTA) showed the anomalous origin of the right coronary artery from the left sinus of Valsalva. Coronary artery unroofing was performed due to an interarterial course with the intramural component, and a permanent epicardial pacemaker was implanted. The postoperative recovery was uneventful, and this patient was thriving and asymptomatic at the nine-month follow-up. However, the electrocardiogram still indicated a complete pacing rhythm. CONCLUSIONS: By timely diagnosis and treatment, this patient is successfully rescued. Although rare, AAOCA may be fatal even in infants.
Sujet(s)
Entraînement électrosystolique , Anomalies congénitales des vaisseaux coronaires , Pacemaker , Humains , Nourrisson , Anomalies congénitales des vaisseaux coronaires/complications , Anomalies congénitales des vaisseaux coronaires/imagerie diagnostique , Anomalies congénitales des vaisseaux coronaires/thérapie , Anomalies congénitales des vaisseaux coronaires/chirurgie , Résultat thérapeutique , Bloc atrioventriculaire/diagnostic , Bloc atrioventriculaire/étiologie , Bloc atrioventriculaire/thérapie , Bloc atrioventriculaire/physiopathologie , Sinus de l'aorte/imagerie diagnostique , Sinus de l'aorte/malformations , Sinus de l'aorte/chirurgie , Sinus de l'aorte/physiopathologie , Arrêt cardiaque/étiologie , Arrêt cardiaque/thérapie , Arrêt cardiaque/diagnostic , Coronarographie , Mâle , Électrocardiographie , Angiographie par tomodensitométrieRÉSUMÉ
OBJECTIVES: With the increase in life expectancy and the aging of the population, chronic kidney disease has become increasingly prevalent in our environment. Kidney transplantation remains the gold standard treatment for end-stage renal disease, but the supply of renal grafts has not been able to keep pace with growing demand. Because of this rationale, organ selection criteria have been extended (expanded criteria donation), and alternative donation types, such as donation after circulatory death, have been evaluated. These approaches aim to increase the pool of potential donors, albeit with organs of potentially lower quality. Various forms of donations, including donation after circulatory death, have also undergone assessment. This approach aims to augment the pool of potential donors, notwithstanding the compromised quality of organs associated with such methods. Diverse strategies have been explored to enhance graft function, with one of the most promising being the utilization of pulsatile machine perfusion. MATERIALS AND METHODS: We conducted a retrospective analysis on 28 transplant recipients who met the inclusion criterion of sharing the same donor, wherein one organ was preserved by cold storage and the other by pulsatile machine perfusion. We performed statistical analysis on posttransplant recovery parameters throughout the patients' hospitalization, including admission and discharge phases. RESULTS: Statistically significant differences were noted in delayed graft function (P = .04), blood transfusions requirements, and Clavien-Dindo complications. Furthermore, an overall trend of improvement in discharge parameters and hospital stay was in favor of the pulsatile machine perfusion group. CONCLUSIONS: The use of pulsatile machine perfusion as a method of renal preservation results in graft optimization, leading to earlier recovery and fewer complications compared with cold storage in the context of donation after circulatory death.
Sujet(s)
Reprise retardée de fonction du greffon , Transplantation rénale , Perfusion , Écoulement pulsatoire , Récupération fonctionnelle , Humains , Transplantation rénale/effets indésirables , Études rétrospectives , Résultat thérapeutique , Facteurs temps , Mâle , Femelle , Perfusion/méthodes , Perfusion/effets indésirables , Adulte d'âge moyen , Adulte , Reprise retardée de fonction du greffon/étiologie , Reprise retardée de fonction du greffon/prévention et contrôle , Facteurs de risque , Donneurs de tissus/ressources et distribution , Conservation d'organe/méthodes , Conservation d'organe/effets indésirables , Sélection de donneurs , Arrêt cardiaque/diagnostic , Arrêt cardiaque/physiopathologie , Arrêt cardiaque/étiologieRÉSUMÉ
Importance: Sudden death and cardiac arrest frequently occur without explanation, even after a thorough clinical evaluation. Calcium release deficiency syndrome (CRDS), a life-threatening genetic arrhythmia syndrome, is undetectable with standard testing and leads to unexplained cardiac arrest. Objective: To explore the cardiac repolarization response on an electrocardiogram after brief tachycardia and a pause as a clinical diagnostic test for CRDS. Design, Setting, and Participants: An international, multicenter, case-control study including individual cases of CRDS, 3 patient control groups (individuals with suspected supraventricular tachycardia; survivors of unexplained cardiac arrest [UCA]; and individuals with genotype-positive catecholaminergic polymorphic ventricular tachycardia [CPVT]), and genetic mouse models (CRDS, wild type, and CPVT were used to define the cellular mechanism) conducted at 10 centers in 7 countries. Patient tracings were recorded between June 2005 and December 2023, and the analyses were performed from April 2023 to December 2023. Intervention: Brief tachycardia and a subsequent pause (either spontaneous or mediated through cardiac pacing). Main Outcomes and Measures: Change in QT interval and change in T-wave amplitude (defined as the difference between their absolute values on the postpause sinus beat and the last beat prior to tachycardia). Results: Among 10 case patients with CRDS, 45 control patients with suspected supraventricular tachycardia, 10 control patients who experienced UCA, and 3 control patients with genotype-positive CPVT, the median change in T-wave amplitude on the postpause sinus beat (after brief ventricular tachycardia at ≥150 beats/min) was higher in patients with CRDS (P < .001). The smallest change in T-wave amplitude was 0.250 mV for a CRDS case patient compared with the largest change in T-wave amplitude of 0.160 mV for a control patient, indicating 100% discrimination. Although the median change in QT interval was longer in CRDS cases (P = .002), an overlap between the cases and controls was present. The genetic mouse models recapitulated the findings observed in humans and suggested the repolarization response was secondary to a pathologically large systolic release of calcium from the sarcoplasmic reticulum. Conclusions and Relevance: There is a unique repolarization response on an electrocardiogram after provocation with brief tachycardia and a subsequent pause in CRDS cases and mouse models, which is absent from the controls. If these findings are confirmed in larger studies, this easy to perform maneuver may serve as an effective clinical diagnostic test for CRDS and become an important part of the evaluation of cardiac arrest.
Sujet(s)
Électrocardiographie , Humains , Souris , Études cas-témoins , Mâle , Animaux , Femelle , Adulte , Tachycardie ventriculaire/diagnostic , Tachycardie ventriculaire/physiopathologie , Tachycardie ventriculaire/étiologie , Arrêt cardiaque/étiologie , Arrêt cardiaque/diagnostic , Calcium/métabolisme , Calcium/sang , Tachycardie supraventriculaire/diagnostic , Tachycardie supraventriculaire/physiopathologie , Tachycardie supraventriculaire/étiologie , Adulte d'âge moyen , Modèles animaux de maladie humaine , Troubles du rythme cardiaque/diagnostic , Troubles du rythme cardiaque/étiologie , Adolescent , Jeune adulte , Canal de libération du calcium du récepteur à la ryanodine/génétiqueRÉSUMÉ
PURPOSE OF REVIEW: Cardiogenic shock is a clinical syndrome with different causes and a complex pathophysiology. Recent evidence from clinical trials evokes the urgent need for redefining clinical diagnostic criteria to be compliant with the definition of cardiogenic shock and current diagnostic methods. RECENT FINDINGS: Conflicting results from randomized clinical trials investigating mechanical circulatory support in patients with cardiogenic shock have elicited several extremely important questions. At minimum, it is questionable whether survivors of cardiac arrest should be included in trials focused on cardiogenic shock. Moreover, considering the wide availability of ultrasound and hemodynamic monitors capable of arterial pressure analysis, the current clinical diagnostic criteria based on the presence of hypotension and hypoperfusion have become insufficient. As such, new clinical criteria for the diagnosis of cardiogenic shock should include evidence of low cardiac output and appropriate ventricular filling pressure. SUMMARY: Clinical diagnostic criteria for cardiogenic shock should be revised to better define cardiac pump failure as a primary cause of hemodynamic compromise.
Sujet(s)
Choc cardiogénique , Choc cardiogénique/diagnostic , Choc cardiogénique/physiopathologie , Choc cardiogénique/thérapie , Choc cardiogénique/étiologie , Humains , Hémodynamique/physiologie , Arrêt cardiaque/thérapie , Arrêt cardiaque/diagnosticRÉSUMÉ
BACKGROUND: Intensive cardiac care units (ICCUs) were created to manage ventricular arrhythmias after acute coronary syndromes, but have diversified to include a more heterogeneous population, the characteristics of which are not well depicted by conventional methods. AIMS: To identify ICCU patient subgroups by phenotypic unsupervised clustering integrating clinical, biological, and echocardiographic data to reveal pathophysiological differences. METHODS: During 7-22 April 2021, we recruited all consecutive patients admitted to ICCUs in 39 centers. The primary outcome was in-hospital major adverse events (MAEs; death, resuscitated cardiac arrest or cardiogenic shock). A cluster analysis was performed using a Kamila algorithm. RESULTS: Of 1499 patients admitted to the ICCU (69.6% male, mean age 63.3±14.9 years), 67 (4.5%) experienced MAEs. Four phenogroups were identified: PG1 (n=535), typically patients with non-ST-segment elevation myocardial infarction; PG2 (n=444), younger smokers with ST-segment elevation myocardial infarction; PG3 (n=273), elderly patients with heart failure with preserved ejection fraction and conduction disturbances; PG4 (n=247), patients with acute heart failure with reduced ejection fraction. Compared to PG1, multivariable analysis revealed a higher risk of MAEs in PG2 (odds ratio [OR] 3.13, 95% confidence interval [CI] 1.16-10.0) and PG3 (OR 3.16, 95% CI 1.02-10.8), with the highest risk in PG4 (OR 20.5, 95% CI 8.7-60.8) (all P<0.05). CONCLUSIONS: Cluster analysis of clinical, biological, and echocardiographic variables identified four phenogroups of patients admitted to the ICCU that were associated with distinct prognostic profiles. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT05063097.
Sujet(s)
Unités de soins intensifs cardiaques , Phénotype , Humains , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Facteurs de risque , Analyse de regroupements , Appréciation des risques , Mortalité hospitalière , Infarctus du myocarde sans sus-décalage du segment ST/thérapie , Infarctus du myocarde sans sus-décalage du segment ST/physiopathologie , Infarctus du myocarde sans sus-décalage du segment ST/mortalité , Infarctus du myocarde sans sus-décalage du segment ST/imagerie diagnostique , Infarctus du myocarde sans sus-décalage du segment ST/diagnostic , Pronostic , Facteurs temps , Choc cardiogénique/physiopathologie , Choc cardiogénique/thérapie , Choc cardiogénique/mortalité , Choc cardiogénique/diagnostic , Études prospectives , Arrêt cardiaque/thérapie , Arrêt cardiaque/physiopathologie , Arrêt cardiaque/diagnostic , Arrêt cardiaque/mortalité , Infarctus du myocarde avec sus-décalage du segment ST/thérapie , Infarctus du myocarde avec sus-décalage du segment ST/physiopathologie , Infarctus du myocarde avec sus-décalage du segment ST/diagnostic , Infarctus du myocarde avec sus-décalage du segment ST/mortalité , Sujet âgé de 80 ans ou plus , Défaillance cardiaque/physiopathologie , Défaillance cardiaque/thérapie , Défaillance cardiaque/diagnostic , Défaillance cardiaque/mortalitéRÉSUMÉ
OBJECTIVE: Although the TyG index is a reliable predictor of insulin resistance (IR) and cardiovascular disease, its effectiveness in predicting major adverse cardiac events in hospitalized acute coronary syndrome (ACS) patients has not been validated in large-scale studies. In this study, we aimed to explore the association between the TyG index and the occurrence of MACEs during hospitalization. METHODS: We recruited ACS patients from the CCC-ACS (Improving Cardiovascular Care in China-ACS) database and calculated the TyG index using the formula ln(fasting triglyceride [mg/dL] × fasting glucose [mg/dL]/2). These patients were classified into four groups based on quartiles of the TyG index. The primary endpoint was the occurrence of MACEs during hospitalization, encompassing all-cause mortality, cardiac arrest, myocardial infarction (MI), and stroke. We performed Cox proportional hazards regression analysis to clarify the correlation between the TyG index and the risk of in-hospital MACEs among patients diagnosed with ACS. Additionally, we explored this relationship across various subgroups. RESULTS: A total of 101,113 patients were ultimately included, and 2759 in-hospital MACEs were recorded, with 1554 (49.1%) cases of all-cause mortality, 601 (21.8%) cases of cardiac arrest, 251 (9.1%) cases of MI, and 353 (12.8%) cases of stroke. After adjusting for confounders, patients in TyG index quartile groups 3 and 4 showed increased risks of in-hospital MACEs compared to those in quartile group 1 [HR = 1.253, 95% CI 1.121-1.400 and HR = 1.604, 95% CI 1.437-1.791, respectively; p value for trend < 0.001], especially in patients with STEMI or renal insufficiency. Moreover, we found interactions between the TyG index and age, sex, diabetes status, renal insufficiency status, and previous PCI (all p values for interactions < 0.05). CONCLUSIONS: In patients with ACS, the TyG index was an independent predictor of in-hospital MACEs. Special vigilance should be exercised in females, elderly individuals, and patients with renal insufficiency.
Sujet(s)
Syndrome coronarien aigu , Marqueurs biologiques , Glycémie , Bases de données factuelles , Valeur prédictive des tests , Triglycéride , Humains , Syndrome coronarien aigu/sang , Syndrome coronarien aigu/mortalité , Syndrome coronarien aigu/diagnostic , Syndrome coronarien aigu/thérapie , Syndrome coronarien aigu/épidémiologie , Femelle , Mâle , Adulte d'âge moyen , Sujet âgé , Chine/épidémiologie , Glycémie/métabolisme , Triglycéride/sang , Marqueurs biologiques/sang , Appréciation des risques , Facteurs de risque , Facteurs temps , Pronostic , Infarctus du myocarde/sang , Infarctus du myocarde/diagnostic , Infarctus du myocarde/mortalité , Infarctus du myocarde/épidémiologie , Infarctus du myocarde/thérapie , Arrêt cardiaque/sang , Arrêt cardiaque/mortalité , Arrêt cardiaque/diagnostic , Arrêt cardiaque/thérapie , Arrêt cardiaque/épidémiologie , Accident vasculaire cérébral/sang , Accident vasculaire cérébral/mortalité , Accident vasculaire cérébral/diagnostic , Accident vasculaire cérébral/épidémiologie , Accident vasculaire cérébral/thérapie , Hospitalisation , Mortalité hospitalièreSujet(s)
Spasme coronaire , Arrêt cardiaque , Transplantation cardiaque , Récidive , Humains , Transplantation cardiaque/effets indésirables , Spasme coronaire/étiologie , Arrêt cardiaque/étiologie , Arrêt cardiaque/diagnostic , Mâle , Adulte d'âge moyen , Résultat thérapeutique , Coronarographie , FemelleRÉSUMÉ
Adrenal insufficiency (AI) is one of the most life-threatening disorders resulting from adrenal cortex dysfunction. Symptoms and signs of AI are often nonspecific, and the diagnosis can be missed and lead to the development of AI with severe hypotension and hypovolemic shock. We report the case of a 13-year-old child admitted for cardiac arrest following severe hypovolemic shock. The patient initially presented with isolated mild abdominal pain and vomiting together with unexplained hyponatremia. He was discharged after an initial short hospitalization with rehydration but with persistent hyponatremia. After discharge, he had persistent refractory vomiting, finally leading to severe dehydration and extreme asthenia. He was admitted to pediatric intensive care after prolonged hypovolemic cardiac arrest with severe anoxic encephalopathy leading to brain death. After re-interviewing, the child's parents reported that he had experienced polydipsia, a pronounced taste for salt with excessive consumption of pickles lasting for months, and a darkened skin since their last vacation 6 months earlier. A diagnosis of autoimmune Addison's disease was made. Primary AI is a rare life-threatening disease that can lead to hypovolemic shock. The clinical symptoms and laboratory findings are nonspecific, and the diagnosis should be suspected in the presence of unexplained collapse, hypotension, vomiting, or diarrhea, especially in the case of hyponatremia.
Sujet(s)
Maladie d'Addison , Humains , Adolescent , Mâle , Maladie d'Addison/diagnostic , Maladie d'Addison/complications , Maladie d'Addison/étiologie , Choc/étiologie , Choc/diagnostic , Hyponatrémie/étiologie , Hyponatrémie/diagnostic , Hyponatrémie/thérapie , Insuffisance surrénale/diagnostic , Insuffisance surrénale/étiologie , Arrêt cardiaque/étiologie , Arrêt cardiaque/diagnosticRÉSUMÉ
BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become a largely used treatment for severe aortic stenosis. There are limited data, however, about predictors of long-term prognosis in this population. In this study, we assessed whether ventricular arrhythmias may predict clinical outcomes in patients undergoing TAVI. METHODS AND RESULTS: We performed a 24âh ECG Holter monitoring in 267 patients who underwent TAVI for severe aortic stenosis within 30âdays from a successful procedure. The occurrence of frequent premature ventricular complexes (PVCs; ≥30/h), polymorphic PVCs and nonsustained ventricular tachycardia (NSVT) was obtained for each patient. Clinical outcome was obtained for 228 patients (85%), for an average follow-up of 3.5âyears (range 1.0-8.6). Cardiovascular events (CVEs; cardiovascular death or resuscitated cardiac arrest) occurred in 26 patients (11.4%) and 63 patients died (27.6%). Frequent PVCs but not polymorphic PVCs and NSVT were found to be associated with CVEs at univariate analysis. Frequent PVCs were indeed found in 12 patients with (46.2%) and 35 without (17.3%) CVEs [hazard ratio 2.30; 95% confidence interval (CI) 1.03-5.09; P â=â0.04], whereas polymorphic PVCs were found in 11 (42.3%) and 54 (26.7%) patients of the two groups, respectively (hazard ratio 1.44; 95% CI 0.64-3.25; P â=â0.38), and NSVT in 9 (34.6%) and 43 patients of the two groups, respectively (hazard ratio 1.18; 95% CI 0.48-2.87; P â=â0.72). Frequent PVCs, however, were not significantly associated with CVEs at multivariate Cox regression analysis (hazard ratio 1.53; 95% CI 0.37-6.30; P â=â0.56). Both frequent PVCs, polymorphic PVCs and NSVT showed no significant association with mortality. CONCLUSION: In our study, the detection of frequent PVCs at Holter monitoring after TAVI was a predictor of CVEs (cardiovascular death/cardiac arrest), but this association was lost in multivariable analysis.
Sujet(s)
Sténose aortique , Arrêt cardiaque , Tachycardie ventriculaire , Remplacement valvulaire aortique par cathéter , Extrasystoles ventriculaires , Humains , Remplacement valvulaire aortique par cathéter/effets indésirables , Extrasystoles ventriculaires/diagnostic , Extrasystoles ventriculaires/épidémiologie , Extrasystoles ventriculaires/étiologie , Tachycardie ventriculaire/diagnostic , Tachycardie ventriculaire/étiologie , Tachycardie ventriculaire/épidémiologie , Sténose aortique/imagerie diagnostique , Sténose aortique/chirurgie , Sténose aortique/étiologie , Arrêt cardiaque/diagnostic , Arrêt cardiaque/étiologie , Arrêt cardiaque/thérapie , Résultat thérapeutique , Valve aortique/imagerie diagnostique , Valve aortique/chirurgieRÉSUMÉ
BACKGROUND: Unwitnessed out-of-hospital cardiac arrest is associated with low survival chances because of the delayed activation of the emergency medical system in most cases. Automated cardiac arrest detection and alarming using biosensor technology would offer a potential solution to provide early help. We developed and validated an algorithm for automated circulatory arrest detection using wrist-derived photoplethysmography from patients with induced circulatory arrests. METHODS: In this prospective multicentre study in three university medical centres in the Netherlands, adult patients (aged 18 years or older) in whom short-lasting circulatory arrest was induced as part of routine practice (transcatheter aortic valve implantation, defibrillation testing, or ventricular tachycardia induction) were eligible for inclusion. Exclusion criteria were a known bilateral significant subclavian artery stenosis or medical issues interfering with the wearing of the wristband. After providing informed consent, patients were equipped with a photoplethysmography wristband during the procedure. Invasive arterial blood pressure and electrocardiography were continuously monitored as the reference standard. Development of the photoplethysmography algorithm was based on three consecutive training cohorts. For each cohort, patients were consecutively enrolled. When a total of 50 patients with at least one event of circulatory arrest were enrolled, that cohort was closed. Validation was performed on the fourth set of included patients. The primary outcome was sensitivity for the detection of circulatory arrest. FINDINGS: Of 306 patients enrolled between March 14, 2022, and April 21, 2023, 291 patients were included in the data analysis. In the development phase (n=205), the first training set yielded a sensitivity for circulatory arrest detection of 100% (95% CI 94-100) and four false positive alarms; the second training set yielded a sensitivity of 100% (94-100), with six false positive alarms; and the third training set yielded a sensitivity of 100% (94-100), with two false positive alarms. In the validation phase (n=86), the sensitivity for circulatory arrest detection was 98% (92-100) and 11 false positive circulatory arrest alarms. The positive predictive value was 90% (95% CI 82-94). INTERPRETATION: The automated detection of induced circulatory arrests using wrist-derived photoplethysmography is feasible with good sensitivity and low false positives. These promising findings warrant further development of this wearable technology to enable automated cardiac arrest detection and alarming in a home setting. FUNDING: Dutch Heart Foundation (Hartstichting).
Sujet(s)
Arrêt cardiaque , Photopléthysmographie , Adulte , Humains , Études prospectives , Arrêt cardiaque/diagnostic , Troubles du rythme cardiaque , AlgorithmesRÉSUMÉ
BACKGROUND: The stress hyperglycaemic ratio (SHR), a new marker that reflects the true hyperglycaemic state of patients with acute coronary syndrome (ACS), is strongly associated with adverse clinical outcomes in these patients. Studies on the relationship between the SHR and in-hospital cardiac arrest (IHCA) incidence are limited. This study elucidated the relationship between the SHR and incidence of IHCA in patients with ACS. METHODS: In total, 1,939 patients with ACS who underwent percutaneous coronary intervention (PCI) at the Affiliated Hospital of Zunyi Medical University were included. They were divided into three groups according to the SHR: group T1 (SHR ≤ 0.838, N = 646), group T2 (0.838< SHR ≤ 1.140, N = 646), and group T3 (SHR3 > 1.140, N = 647). The primary endpoint was IHCA incidence. RESULTS: The overall IHCA incidence was 4.1% (N = 80). After adjusting for covariates, SHR was significantly associated with IHCA incidence in patients with ACS who underwent PCI (odds ratio [OR] = 2.6800; 95% confidence interval [CI] = 1.6200-4.4300; p<0.001), and compared with the T1 group, the T3 group had an increased IHCA risk (OR = 2.1800; 95% CI = 1.2100-3.9300; p = 0.0090). In subgroup analyses, after adjusting for covariates, patients with ST-segment elevation myocardial infarction (STEMI) (OR = 3.0700; 95% CI = 1.4100-6.6600; p = 0.0050) and non-STEMI (NSTEMI) (OR = 2.9900; 95% CI = 1.1000-8.1100; p = 0.0310) were at an increased IHCA risk. After adjusting for covariates, IHCA risk was higher in patients with diabetes mellitus (DM) (OR = 2.5900; 95% CI = 1.4200-4.7300; p = 0.0020) and those without DM (non-DM) (OR = 3.3000; 95% CI = 1.2700-8.5800; p = 0.0140); patients with DM in the T3 group had an increased IHCA risk compared with those in the T1 group (OR = 2.4200; 95% CI = 1.0800-5.4300; p = 0.0320). The restriction cubic spline (RCS) analyses revealed a dose-response relationship between IHCA incidence and SHR, with an increased IHCA risk when SHR was higher than 1.773. Adding SHR to the baseline risk model improved the predictive value of IHCA in patients with ACS treated with PCI (net reclassification improvement [NRI]: 0.0734 [0.0058-0.1409], p = 0.0332; integrated discrimination improvement [IDI]: 0.0218 [0.0063-0.0374], p = 0.0060). CONCLUSIONS: In patients with ACS treated with PCI, the SHR was significantly associated with the incidence of IHCA. The SHR may be a useful predictor of the incidence of IHCA in patients with ACS. The addition of the SHR to the baseline risk model had an incremental effect on the predictive value of IHCA in patients with ACS treated with PCI.
Sujet(s)
Syndrome coronarien aigu , Diabète , Arrêt cardiaque , Hyperglycémie , Infarctus du myocarde sans sus-décalage du segment ST , Intervention coronarienne percutanée , Infarctus du myocarde avec sus-décalage du segment ST , Humains , Syndrome coronarien aigu/diagnostic , Syndrome coronarien aigu/épidémiologie , Syndrome coronarien aigu/thérapie , Études rétrospectives , Hyperglycémie/diagnostic , Hyperglycémie/épidémiologie , Hyperglycémie/complications , Intervention coronarienne percutanée/effets indésirables , Incidence , Diabète/étiologie , Infarctus du myocarde sans sus-décalage du segment ST/thérapie , Infarctus du myocarde avec sus-décalage du segment ST/diagnostic , Infarctus du myocarde avec sus-décalage du segment ST/épidémiologie , Infarctus du myocarde avec sus-décalage du segment ST/thérapie , Arrêt cardiaque/diagnostic , Arrêt cardiaque/épidémiologie , Arrêt cardiaque/thérapie , Résultat thérapeutique , Facteurs de risqueRÉSUMÉ
PURPOSE: The 2021 guidelines endorsed by the European Resuscitation Council (ERC) and the European Society of Intensive Care Medicine (ESICM) recommend using highly malignant electroencephalogram (EEG) patterns (HMEP; suppression or burst-suppression) at > 24 h after cardiac arrest (CA) in combination with at least one other concordant predictor to prognosticate poor neurological outcome. We evaluated the prognostic accuracy of HMEP in a large multicentre cohort and investigated the added value of absent EEG reactivity. METHODS: This is a pre-planned prognostic substudy of the Targeted Temperature Management trial 2. The presence of HMEP and background reactivity to external stimuli on EEG recorded > 24 h after CA was prospectively reported. Poor outcome was measured at 6 months and defined as a modified Rankin Scale score of 4-6. Prognostication was multimodal, and withdrawal of life-sustaining therapy (WLST) was not allowed before 96 h after CA. RESULTS: 845 patients at 59 sites were included. Of these, 579 (69%) had poor outcome, including 304 (36%) with WLST due to poor neurological prognosis. EEG was recorded at a median of 71 h (interquartile range [IQR] 52-93) after CA. HMEP at > 24 h from CA had 50% [95% confidence interval [CI] 46-54] sensitivity and 93% [90-96] specificity to predict poor outcome. Specificity was similar (93%) in 541 patients without WLST. When HMEP were unreactive, specificity improved to 97% [94-99] (p = 0.008). CONCLUSION: The specificity of the ERC-ESICM-recommended EEG patterns for predicting poor outcome after CA exceeds 90% but is lower than in previous studies, suggesting that large-scale implementation may reduce their accuracy. Combining HMEP with an unreactive EEG background significantly improved specificity. As in other prognostication studies, a self-fulfilling prophecy bias may have contributed to observed results.
Sujet(s)
Réanimation cardiopulmonaire , Arrêt cardiaque , Hypothermie provoquée , Humains , Réanimation cardiopulmonaire/méthodes , Soins de réanimation , Électroencéphalographie/méthodes , Arrêt cardiaque/diagnostic , Arrêt cardiaque/thérapie , Hypothermie provoquée/méthodes , Pronostic , Essais cliniques comme sujet , Études multicentriques comme sujetRÉSUMÉ
Cardiac arrest prediction for multivariate time series data have been developed and obtained high precision performance. However, these algorithms still did not achieved high sensitivity and suffer from a high false-alarm. Therefore, we propose a ensemble approach for prediction satisfying precision-recall result compared than other machine learning methods. As a result, our proposed method obtained an overall area under precision-recall curve of 46.7%. It is possible to more accurately respond rapidly cardiac arrest event.